217 related articles for article (PubMed ID: 7681119)
1. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS
J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119
[TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H
J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870
[TBL] [Abstract][Full Text] [Related]
3. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG
Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734
[TBL] [Abstract][Full Text] [Related]
4. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands.
Iwakiri J; Granbois K; Wehner N; Graves HC; Stamey T
J Urol; 1993 Apr; 149(4):783-6. PubMed ID: 7681118
[TBL] [Abstract][Full Text] [Related]
5. Use of serum concentration techniques to enhance early detection of recurrent prostate cancer after radical prostatectomy.
Pruthi RS; Haese A; Huland E; Stamey TA
Urology; 1997 Mar; 49(3):404-10. PubMed ID: 9123706
[TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.
Tilki D; Kim SI; Hu B; Dall'Era MA; Evans CP
J Urol; 2015 May; 193(5):1525-31. PubMed ID: 25444980
[TBL] [Abstract][Full Text] [Related]
7. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
[TBL] [Abstract][Full Text] [Related]
8. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy.
Nakamura M; Hasumi H; Miyoshi Y; Sugiura S; Fujinami K; Yao M; Kubota Y; Uemura H
Int J Urol; 2005 Dec; 12(12):1050-4. PubMed ID: 16409609
[TBL] [Abstract][Full Text] [Related]
11. Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up.
Vassilikos EJ; Yu H; Trachtenberg J; Nam RK; Narod SA; Bromberg IL; Diamandis EP
Clin Biochem; 2000 Mar; 33(2):115-23. PubMed ID: 10751589
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy.
Prestigiacomo AF; Stamey TA
J Urol; 1994 Nov; 152(5 Pt 1):1515-9. PubMed ID: 7523709
[TBL] [Abstract][Full Text] [Related]
13. Does seminal vesicle-sparing robotic radical prostatectomy influence postoperative prostate-specific antigen measured with an ultrasensitive immunoassay?
Burkhardt O; Neuenschwander JE; John H; Randazzo M
Swiss Med Wkly; 2018 Nov; 148():w14685. PubMed ID: 30474852
[TBL] [Abstract][Full Text] [Related]
14. Ultrasensitive assay of prostate-specific antigen for early detection of residual cancer after radical prostatectomy.
Arai Y; Okubo K; Aoki Y; Maekawa S; Okada T; Maeda H
Int J Urol; 1998 Nov; 5(6):550-5. PubMed ID: 9855123
[TBL] [Abstract][Full Text] [Related]
15. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.
Witherspoon LR; Lapeyrolerie T
J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931
[TBL] [Abstract][Full Text] [Related]
16. Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay.
Haab F; Meulemans A; Boccon-Gibod L; Dauge MC; Delmas V; Hennequin C; Benbunan D; Boccon-Gibod L
Urology; 1995 Jun; 45(6):1022-7. PubMed ID: 7539559
[TBL] [Abstract][Full Text] [Related]
17. A brief review of ultrasensitive prostate-specific antigen assays for the evaluation of patients after radical prostatectomy.
Takayama TK; Vessella RL; Lange PH
World J Urol; 1993; 11(4):192-5. PubMed ID: 7508782
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
Shen S; Lepor H; Yaffee R; Taneja SS
J Urol; 2005 Mar; 173(3):777-80. PubMed ID: 15711268
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy.
Yu H; Diamandis EP; Prestigiacomo AF; Stamey TA
Clin Chem; 1995 Mar; 41(3):430-4. PubMed ID: 7533672
[TBL] [Abstract][Full Text] [Related]
20. Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
Malik RD; Goldberg JD; Hochman T; Lepor H
Eur Urol; 2011 Sep; 60(3):548-53. PubMed ID: 21652145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
